A. Forslund et al., Serum anti-p53 in relation to mutations across the entire translated p53 gene in colorectal carcinomas, INT J ONCOL, 19(3), 2001, pp. 501-506
Previous reports have claimed that antibodies to mutated p53 protein indica
te poor outcome in malignant disease. The mechanism behind this highly spec
ific process is unclear, although it has been claimed that certain DNA alte
rations are prone to induction of immune response, since wild-type p53 is a
lmost never immunogenic. The aim of the present analysis was to evaluate wh
ether the presence of anti-p53 was statistically significantly related to a
ny certain DNA alterations in the entirely expressed p53 gene in primary tu
mors of colorectal cancer. P53 serum antibodies were determined by an enzym
e linked immunosorbant assay (ELISA). P53 antibodies were detected in serum
of 24 of 88 patients (27%). Twenty-two of 24 (92%) sero-positive patients
had mutations in their p53 gene while only 22 of 64 (34%) sero-negative pat
ients had p53 mutations (p<0.01). Mutations were mainly missense with a tre
nd to significantly higher frequency of deletions in sero-negative patients
compared to sero-positive subjects (8/25, 32% and 2/22, 9% respectively, p
<0.08). Mutations in sero-positive patients were mainly located in exon 5 a
nd 7 and within conserved regions (17 of 22 mutations). In sero-negative pa
tients missense mutations were usually located in exon 5, 7 and 8 being als
o most frequently located within conserved regions. Most of the p53 deletio
ns in sero-negative patients were however located outside conserved regions
(seven of eight deletions). There was no statistical difference between se
ro-positive and negative patients concerning the spectrum of mutations alon
g the expressed gene. Our study demonstrates that p53 antibodies are usuall
y related to p53 gene mutations but a mutational event is not sufficient to
elicit self-immunization. Cellular protein binding to p53 or individual di
fferences of major histocompatibility complex based presentation of p53 pro
tein sequences by immune cells is therefore the most likely explanation bet
ween sero-negative and sero-positive patients.